抗連環(huán)蛋白β1(β-catenin)單克隆抗體
Anti-Beta Catenin (β-catenin) Monoclonal Antibody
CTNNb1; bCat; b-Cat; CTNN-B1; Catenin Beta 1; Cadherin-Associated Protein
- 編號(hào)UCAB021Mi22
 - 物種Homo sapiens (Human,人), Mus musculus (Mouse,小鼠), Rattus norvegicus (Rat,大鼠) 相同的名稱,不同的物種。
 - 純化方式蛋白A + 蛋白G親和純化
 - 標(biāo)記物無(wú)標(biāo)記物
 - 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
 - 性狀液體
 - 濃度1mg/mL
 - 且適物種Homo sapiens (Human,人), Mus musculus (Mouse,小鼠), Rattus norvegicus (Rat,大鼠), Canis familiaris; Canine (Dog,犬), Sus scrofa; Porcine (Pig,豬), Bos taurus; Bovine (Cattle,牛), Chicken (Gallus,雞)
 - 應(yīng)用WB
 - 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
 - 規(guī)格 20μl100μl 200μl 1ml 10ml
 - 價(jià)格 ¥ 358 ¥ 836 ¥ 1194 ¥ 2985 ¥ 11940
 - 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
特異性
該抗體是針對(duì)β-catenin的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別β-catenin。
用法
            Western blottin:g: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.        
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過(guò)兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
            抗體標(biāo)記定制服務(wù)
                    Protein-A/G純化柱
                    細(xì)胞和組織染色液
                    抗體陽(yáng)性對(duì)照品
                    組織/切片定制服務(wù)
                    磷酸化抗體定制服務(wù)
                    免疫印跡(WB)實(shí)驗(yàn)服務(wù)
                    免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
                    免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
                    流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
                    免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
                    免疫熒光(IF)實(shí)驗(yàn)服務(wù)
                    緩沖液
                    DAB顯色試劑盒
                    SABC試劑盒
                    長(zhǎng)臂生物素標(biāo)記試劑盒
                    實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
                            
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種:Homo sapiens (Human,人), Mus musculus (Mouse,小鼠), Rattus norvegicus (Rat,大鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| UCAB021Mi01 | 抗連環(huán)蛋白β1(β-catenin)多克隆抗體 | WB | 
| UCAB021Mi22 | 抗連環(huán)蛋白β1(β-catenin)單克隆抗體 | WB | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| Clinica Chimica Acta | Versican and its associated molecules: Potential diagnostic markers for multiple myeloma [Pubmed:25623955] | 
| Journal of Bone and Mineral Research | Adverse effects of osteocytic constitutive activation of ?-catenin on bone strength and bone growth [Pubmed:25639729] | 
| Am J Transl Res | Role of SDF-1 and Wnt signaling pathway in the myocardial fibrosis of hypertensive rats [PubMed: 26396666] | 
| Scientific Reports | Is there an association between enhanced choline and β-catenin pathway in breast cancer? A pilot study by MR Spectroscopy and ELISA. [pubmed:28533512] | 
| Life Sciences | Hepatoprotective effect of hesperidin in hepatocellular carcinoma: Involvement of Wnt signaling pathways. [pubmed:28754618] | 
| Scientific Reports | Is there an association between enhanced choline and β-catenin pathway in breast cancer? A pilot study by MR Spectroscopy and ELISA [Pubmed: 28533512] | 
| The Showa University Journal of Medical Sciences | Eribulin Treatment Induces High Expression of miR-195 and Inactivates the Wnt/β-catenin Signaling Pathway in Triple-negative Breast Cancer [Doi: 10.15369/sujms.30.359] | 
| Advances in?Medical?Sciences | Urinary procollagen III aminoterminal propeptide and β-catenin–New diagnostic biomarkers in solitary functioning kidney? [Pubmed: 30738287] | 
| Biomed Pharmacother | Silence of FAM83H-AS1 promotes chemosensitivity of gastric cancer through Wnt/β-catenin signaling pathway [Pubmed: 32028241] | 
| Journal of Cosmetic Dermatology | Novel complex of cosmetic ingredients with promising action in preventing hair loss and follicular aging through mechanism involving enrichment of WNT/signaling?… [Pubmed: 33179848] | 
| Nutrients | Hydroxytyrosol as a Promising Ally in the Treatment of Fibromyalgia [Pubmed: 32784915] | 
| Oncotarget | Amalgamation of PI3K and EZH2 blockade synergistically regulates invasion and angiogenesis: combination therapy for glioblastoma multiforme [33473259] | 
| Cytokine | QNZ alleviated hepatocellular carcinoma by targeting inflammatory pathways in a rat model [34564023] | 

                    
                    
                            